| 1 | (S)-N-(1-deutero-1-(3-chloro-5-fluoro-2-((2-methyl-4-(1-methyl-1H-1,2,4-triazol-5-yl)quinolin-8-yloxy)methyl)phenyl)ethyl)-2-(difluoromethoxy)acetamide | [1] Acetamide Acetamide | - | - | - | [1] 65 65 💬
|
| 2 | 16,5% Cutaquig | - | - | - | - | [1] 65 65 💬
|
| 3 | 36-482-Hyaluronoglucosaminidase PH20 (rHuPH20) | [1] Hyaluronidase Hyaluronidase | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| - | - | [1] 65 65 💬
|
| 4 | [BCX7353] | [1] Berotralstat Berotralstat | [2] Berotralstat
Berotralstat
,
Berotralstat hydrochloride
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 5 | [CDZ173] | - | - | - | - | [1] 65 65 💬
|
| 6 | [CSL312 garadacimab] | [1] Garadacimab Garadacimab | [1] Garadacimab
Garadacimab
💬
| [1] F12 F12 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [2] 65 65, 85 💬
|
| 7 | [CSL312] | - | - | - | - | [1] 65 65 💬
|
| 8 | [Dexamethasone sodium phosphate] | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 9 | [DX-2930] | - | - | - | - | [1] 65 65 💬
|
| 10 | [Firazyr] | - | - | - | - | [1] 65 65 💬
|
| 11 | [ISIS 721744] | - | - | - | - | [1] 65 65 💬
|
| 12 | [KIg10] | - | - | - | - | [1] 65 65 💬
|
| 13 | [KVD900 100 mg Film Coated Tablet] | - | - | - | - | [1] 65 65 💬
|
| 14 | [KVD900 300 mg Film Coated Tablet] | - | - | - | - | [1] 65 65 💬
|
| 15 | [KVD900] | - | - | - | - | [1] 65 65 💬
|
| 16 | [N/A] | - | - | - | - | [11] 2 2, 11, 13, 20, 28, 46, 51, 61, 65, 97, 299 💬
|
| 17 | [NA] | - | - | - | - | [34] 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 18 | [Newnorm] | - | - | - | - | [1] 65 65 💬
|
| 19 | [PHA-022121] | - | - | - | - | [1] 65 65 💬
|
| 20 | [X4P-001] | - | - | - | - | [1] 65 65 💬
|
| 21 | A10BK03 | - | - | - | - | [1] 65 65 💬
|
| 22 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [28] 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
|
| 23 | Accu Chek | - | - | - | - | [2] 65 65, 257 💬
|
| 24 | Acetamide | [1] Acetamide Acetamide | - | - | - | [3] 65 65, 86, 154 💬
|
| 25 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 26 | Adagen | - | - | - | - | [1] 65 65 💬
|
| 27 | Adenosine | [1] Adenosine Adenosine | [1] Adenosine
Adenosine
💬
| [4] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3 💬
| [13] Alcoholism Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 13 13, 57, 58, 65 💬
|
| 28 | Administration of drug (Interferon-gamma 1-b) subcutaneously | - | - | - | - | [1] 65 65 💬
|
| 29 | Adverse Reactions of Gammagard subcutaneously at Week 12 | - | - | - | - | [1] 65 65 💬
|
| 30 | Adverse Reactions of Gammagard subcutaneously at Week 24 | - | - | - | - | [1] 65 65 💬
|
| 31 | Adverse Reactions of Gammagard subcutaneously at Week 36 | - | - | - | - | [1] 65 65 💬
|
| 32 | Adverse Reactions of Gammagard subdermally at Week 12 | - | - | - | - | [1] 65 65 💬
|
| 33 | Adverse Reactions of Gammagard subdermally at Week 24 | - | - | - | - | [1] 65 65 💬
|
| 34 | Adverse Reactions of Gammagard subdermally at Week 36 | - | - | - | - | [1] 65 65 💬
|
| 35 | ADX-324 | - | - | - | - | [1] 65 65 💬
|
| 36 | ADX-324 Dose Level 1 | - | - | - | - | [1] 65 65 💬
|
| 37 | ADX-324 Dose Level 2 | - | - | - | - | [1] 65 65 💬
|
| 38 | Aldesleukin | [1] Aldesleukin Aldesleukin | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA, IL2RB, IL2RG 💬
| [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [5] 2 2, 49, 65, 96, 97 💬
|
| 39 | Alefacept | [1] Alefacept Alefacept | [1] Alefacept
Alefacept
💬
| [1] CD58 CD58 💬
| [2] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, Epstein-Barr virus infection 💬 | [6] 37 37, 60, 65, 164, 284, 285 💬
|
| 40 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [21] 13 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
|
| 41 | Alemtuzumab 0.2 mg | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [2] 65 65, 164 💬
|
| 42 | Alemtuzumab 0.3 mg | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [2] 65 65, 164 💬
|
| 43 | Allo BMT | - | - | - | - | [1] 65 65 💬
|
| 44 | Allogeneic Bone Marrow Transplantation | - | - | - | - | [8] 60 60, 62, 65, 96, 164, 284, 285, 286 💬
|
| 45 | Allogeneic hematopoietic stem cell transplantation | - | - | - | - | [8] 28 28, 51, 60, 62, 65, 164, 284, 285 💬
|
| 46 | Allogeneic HSC | - | - | - | - | [1] 65 65 💬
|
| 47 | Allogeneic HSCT | - | - | - | - | [1] 65 65 💬
|
| 48 | Allogeneic peripheral blood stem cell | - | - | - | - | [1] 65 65 💬
|
| 49 | Anti-CD45 | - | - | - | - | [2] 65 65, 285 💬
|
| 50 | Anti-Thymocyte Globulin | - | - | - | - | [19] 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
|
| 51 | Antisense oligonucleotide targeting the ATM gene | - | - | - | - | [1] 65 65 💬
|
| 52 | Antithymocyte Globulin | - | - | - | - | [3] 60 60, 65, 284 💬
|
| 53 | AP1903 | - | - | - | - | [4] 60 60, 65, 285, 326 💬
|
| 54 | Ara-C | - | - | - | - | [1] 65 65 💬
|
| 55 | Argininhydrochlorid | - | - | - | - | [1] 65 65 💬
|
| 56 | Asceniv™ | - | - | - | - | [1] 65 65 💬
|
| 57 | AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR | - | - | - | - | [1] 65 65 💬
|
| 58 | Autologous CD34+ cells transduced with the G1XCGD lentiviral vector | - | - | - | - | [1] 65 65 💬
|
| 59 | Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy | - | - | - | - | [1] 65 65 💬
|
| 60 | Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence | - | - | - | - | [1] 65 65 💬
|
| 61 | Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene | - | - | - | - | [1] 65 65 💬
|
| 62 | AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR | - | - | - | - | [1] 65 65 💬
|
| 63 | Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV) | [1] Adenosine Adenosine | [1] Adenosine
Adenosine
💬
| [4] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3 💬
| [13] Alcoholism Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 64 | Avoralstat | [1] Avoralstat Avoralstat | - | - | - | [1] 65 65 💬
|
| 65 | AVTX-803 | - | - | - | - | [1] 65 65 💬
|
| 66 | AVTX-803 (L-Fucose) | [1] Fucose Fucose | [1] Elfucose
Elfucose
💬
| - | - | [1] 65 65 💬
|
| 67 | Azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [26] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 68 | B-Lymphocyte Stimulator (BLyS) | - | - | - | - | [1] 65 65 💬
|
| 69 | Baclofen | [1] Baclofen Baclofen | [1] Baclofen
Baclofen
💬
| [2] GABBR1 GABBR1, GABBR2 💬
| [8] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [8] 2 2, 10, 13, 18, 65, 70, 149, 206 💬
|
| 70 | Bacteriophage | - | - | - | - | [1] 65 65 💬
|
| 71 | Baricitinib | [1] Baricitinib Baricitinib | [1] Baricitinib
Baricitinib
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [24] 2 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
|
| 72 | Base-edited hematopoietic stem and progenitor cells | - | - | - | - | [1] 65 65 💬
|
| 73 | BC7353 | - | - | - | - | [1] 65 65 💬
|
| 74 | BCX4161 | [1] Avoralstat Avoralstat | - | - | - | [1] 65 65 💬
|
| 75 | BCX7353 | [1] Berotralstat Berotralstat | [2] Berotralstat
Berotralstat
,
Berotralstat hydrochloride
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 76 | BCX7353 + digoxin | [1] Digoxin Digoxin | [1] Digoxin
Digoxin
💬
| [4] ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬
| [19] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 77 | BCX7353 and probes | - | - | - | - | [1] 65 65 💬
|
| 78 | BCX7353 capsules | - | - | - | - | [1] 65 65 💬
|
| 79 | Behavioral: Symptom diary | - | - | - | - | [1] 65 65 💬
|
| 80 | Berinert | - | - | - | - | [1] 65 65 💬
|
| 81 | Berinert P | - | - | - | - | [1] 65 65 💬
|
| 82 | BERINERT*IV FL 500U+FL 10ML | - | - | - | - | [1] 65 65 💬
|
| 83 | Berinert, lyophilizate for IV application containing 500 IU C1-INH to be reconstituted with 10 mL water for injection | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 65 65 💬
|
| 84 | Berinert® | - | - | - | - | [1] 65 65 💬
|
| 85 | Berinert® (C1 Esterase Inhibitor) | - | - | - | - | [1] 65 65 💬
|
| 86 | Berinert® P | - | - | - | - | [1] 65 65 💬
|
| 87 | Berinert®, 20 ??/ kg | - | - | - | - | [1] 65 65 💬
|
| 88 | BEROTRALSTAT | [1] Berotralstat Berotralstat | [2] Berotralstat
Berotralstat
,
Berotralstat hydrochloride
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 89 | Betamethasone | [1] Betamethasone Betamethasone | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
,
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 2 2, 28, 46, 56, 65, 83, 90, 96, 235 💬
|
| 90 | Betamethasone Oral Solution Period 1 and Period 2 | [1] Betamethasone Betamethasone | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
,
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 91 | Betamethasone solution as intramuscular injection Period 1 and Period 2 | [1] Betamethasone Betamethasone | [6] Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
,
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 92 | Bioelectrical impedance analysis | - | - | - | - | [1] 65 65 💬
|
| 93 | Biological NTLA-2002 | [1] NTLA-2002 NTLA-2002 | - | - | - | [1] 65 65 💬
|
| 94 | Biological sampling | - | - | - | - | [2] 65 65, 97 💬
|
| 95 | Biopsy | - | - | - | - | [7] 28 28, 34, 51, 65, 97, 193, 285 💬
|
| 96 | Biopsy Procedure | - | - | - | - | [1] 65 65 💬
|
| 97 | Biospecimen Collection | - | - | - | - | [18] 13 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
|
| 98 | Bivigam | - | - | - | - | [1] 65 65 💬
|
| 99 | Blood Collection | - | - | - | - | [5] 21 21, 65, 201, 229, 271 💬
|
| 100 | Blood draw | - | - | - | - | [16] 3 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
|
| 101 | Blood sample | - | - | - | - | [33] 2 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
|
| 102 | Blood withdrawal | - | - | - | - | [3] 13 13, 48, 65 💬
|
| 103 | BMN 331 | - | - | - | - | [1] 65 65 💬
|
| 104 | BMS-188667 | - | - | - | - | [10] 46 46, 49, 53, 65, 96, 97, 107, 222, 223, 271 💬
|
| 105 | Bone Marrow Aspiration | - | - | - | - | [7] 28 28, 60, 62, 65, 284, 285, 286 💬
|
| 106 | Bone Marrow Biopsy | - | - | - | - | [7] 26 26, 28, 60, 62, 65, 284, 286 💬
|
| 107 | Boya IVIG | - | - | - | - | [1] 65 65 💬
|
| 108 | BP-SCIG 20% | - | - | - | - | [1] 65 65 💬
|
| 109 | BPX-501 T cells | - | - | - | - | [4] 65 65, 284, 285, 326 💬
|
| 110 | BT090 | - | - | - | - | [1] 65 65 💬
|
| 111 | BT524 | - | - | - | - | [1] 65 65 💬
|
| 112 | BT595 | - | - | - | - | [2] 63 63, 65 💬
|
| 113 | BT681 | - | - | - | - | [1] 65 65 💬
|
| 114 | BUSILVEX | - | - | - | - | [4] 19 19, 36, 60, 65 💬
|
| 115 | BUSILVEX - 6 MG/ML - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 10 ML 8 FLACONCINI | - | - | - | - | [2] 19 19, 65 💬
|
| 116 | Busulfan | [1] Busulfan Busulfan | [1] Busulfan
Busulfan
💬
| - | - | [14] 19 19, 20, 28, 34, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
|
| 117 | Busulfan test dose | [1] Busulfan Busulfan | [1] Busulfan
Busulfan
💬
| - | - | [1] 65 65 💬
|
| 118 | Busulfan, Cyclophosphamide, ATG, GCSF | [2] Busulfan Busulfan, Cyclophosphamide | [3] Busulfan
Busulfan
,
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
| 119 | Busulfan, Fludarabine, ATG, TLI | [2] Busulfan Busulfan, Fludarabine | [3] Busulfan
Busulfan
,
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 284 💬
|
| 120 | BW-20805 | - | - | - | - | [1] 65 65 💬
|
| 121 | C-1-esterase | - | - | - | - | [1] 65 65 💬
|
| 122 | C01EB19 | - | - | - | - | [1] 65 65 💬
|
| 123 | C1 ESTERASE INHIBITOR | - | - | - | - | [1] 65 65 💬
|
| 124 | C1 ESTERASE INHIBITOR (HUMAN) | - | - | - | - | [1] 65 65 💬
|
| 125 | C1 esterase inhibitor [human] | - | - | - | - | [1] 65 65 💬
|
| 126 | C1 esterase inhibitor [human] (C1INH-nf) | - | - | - | - | [1] 65 65 💬
|
| 127 | C1 esterase inhibitor [human] liquid | - | - | - | - | [1] 65 65 💬
|
| 128 | C1 esterase inhibitor concentrate | - | - | - | - | [1] 65 65 💬
|
| 129 | C1 esterase inhibitor concentrate, human, pasteurized | - | - | - | - | [1] 65 65 💬
|
| 130 | C1 Esterase Inhibitor Human | - | - | - | - | [1] 65 65 💬
|
| 131 | C1 esterase inhibitor liquid for injection | - | - | - | - | [1] 65 65 💬
|
| 132 | C1 inhibitor (human) [C1 INH] | - | - | - | - | [1] 65 65 💬
|
| 133 | C1 inhibitor concentrate | - | - | - | - | [1] 65 65 💬
|
| 134 | C1-Esterase Inhibitor | - | - | - | - | [1] 65 65 💬
|
| 135 | C1-esterase inhibitor - single intravenous dose | - | - | - | - | [1] 65 65 💬
|
| 136 | C1-esterase inhibitor - subcutaneous high dose | - | - | - | - | [1] 65 65 💬
|
| 137 | C1-esterase inhibitor - subcutaneous low dose | - | - | - | - | [1] 65 65 💬
|
| 138 | C1-esterase inhibitor - subcutaneous medium dose | - | - | - | - | [1] 65 65 💬
|
| 139 | C1-esterase inhibitor [recombinant] (C1-INH-R) | - | - | - | - | [1] 65 65 💬
|
| 140 | C1-Esterase-Inhibitor | - | - | - | - | [1] 65 65 💬
|
| 141 | Campath -1H | - | - | - | - | [1] 65 65 💬
|
| 142 | Campath 1H | - | - | - | - | [4] 60 60, 65, 164, 285 💬
|
| 143 | Campath, Fludarabine, Cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [4] Cyclophosphamide
Cyclophosphamide
,
Fludarabine phosphate
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 284 💬
|
| 144 | Campath-1H | - | - | - | - | [6] 19 19, 20, 60, 65, 234, 326 💬
|
| 145 | Catapresan 75, Tabletten | - | - | - | - | [1] 65 65 💬
|
| 146 | CD3/CD19 neg allogeneic BMT | - | - | - | - | [1] 65 65 💬
|
| 147 | CD3/CD19 negative allogeneic hematopoietic stem cells | - | - | - | - | [1] 65 65 💬
|
| 148 | CD34 Stem Cell Selection Therapy | - | - | - | - | [3] 60 60, 65, 284 💬
|
| 149 | CD34+ | - | - | - | - | [1] 65 65 💬
|
| 150 | CD34+ cell enriched stem cell graft | - | - | - | - | [2] 65 65, 285 💬
|
| 151 | CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1a-h?c-OPT | - | - | - | - | [1] 65 65 💬
|
| 152 | CD34+CELLS | - | - | - | - | [2] 65 65, 285 💬
|
| 153 | CDZ173 | - | - | - | - | [2] 53 53, 65 💬
|
| 154 | CE1145 | - | - | - | - | [1] 65 65 💬
|
| 155 | Chemotherapy, intrathecal chemotherapy, steroid therapy | - | - | - | - | [1] 65 65 💬
|
| 156 | CINRYZE | - | - | - | - | [1] 65 65 💬
|
| 157 | CINRYZE 1000 | - | - | - | - | [1] 65 65 💬
|
| 158 | CINRYZE 1000 U | - | - | - | - | [1] 65 65 💬
|
| 159 | CINRYZE 500 | - | - | - | - | [1] 65 65 💬
|
| 160 | CINRYZE 500 U | - | - | - | - | [1] 65 65 💬
|
| 161 | CINRYZE with rHuPH20 | - | - | - | - | [1] 65 65 💬
|
| 162 | CINRYZE® | - | - | - | - | [1] 65 65 💬
|
| 163 | CliniMACS | - | - | - | - | [2] 60 60, 65 💬
|
| 164 | Clonidine | [1] Clonidine Clonidine | [2] Clonidine
Clonidine
,
Clonidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [3] 6 6, 65, 70 💬
|
| 165 | Clonidinhydrochlorid | - | - | - | - | [1] 65 65 💬
|
| 166 | CMV-VST | - | - | - | - | [1] 65 65 💬
|
| 167 | Code ATC:L01XC04 | - | - | - | - | [1] 65 65 💬
|
| 168 | Collection of samples | - | - | - | - | [4] 49 49, 65, 95, 107 💬
|
| 169 | COMPLEMENT C1 ESTERASE INHIBITOR | - | - | - | - | [2] 61 61, 65 💬
|
| 170 | Computed Tomography | - | - | - | - | [13] 26 26, 28, 34, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
|
| 171 | CONESTAT ALFA | [1] Conestat alfa Conestat alfa | [1] Conestat alfa
Conestat alfa
💬
| [3] C1R C1R, C1S, KLKB1 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 65 65 💬
|
| 172 | Conjugated pneumococcal vaccine (Prevenar) | - | - | - | - | [1] 65 65 💬
|
| 173 | Continuous Glucose Monitor | - | - | - | - | [2] 65 65, 298 💬
|
| 174 | COVID-19 Vaccine Moderna | - | - | - | - | [5] 46 46, 51, 65, 272, 299 💬
|
| 175 | Cryopreserved Autologous CD34+ cells transduced with pCCLCHIM-p47 | - | - | - | - | [1] 65 65 💬
|
| 176 | Cryopreserved EFS-ADA LV transduced patient CD34+ cells | - | - | - | - | [1] 65 65 💬
|
| 177 | Cryopreserved G2SCID lentiviral vector transduced patient CD34+ cells | - | - | - | - | [1] 65 65 💬
|
| 178 | CSL312 | - | - | - | - | [2] 65 65, 85 💬
|
| 179 | CSL312 garadacimab | [1] Garadacimab Garadacimab | [1] Garadacimab
Garadacimab
💬
| [1] F12 F12 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [2] 65 65, 85 💬
|
| 180 | CSL830 | - | - | - | - | [1] 65 65 💬
|
| 181 | CT Scan | - | - | - | - | [1] 65 65 💬
|
| 182 | Cultured Thymus Tissue | - | - | - | - | [1] 65 65 💬
|
| 183 | Cultured Thymus Tissue for Implantation (CTTI) | - | - | - | - | [1] 65 65 💬
|
| 184 | Cultured Thymus Tissue Implantation (CTTI) | - | - | - | - | [1] 65 65 💬
|
| 185 | CUTAQUIG | - | - | - | - | [1] 65 65 💬
|
| 186 | CUVITRU | - | - | - | - | [1] 65 65 💬
|
| 187 | Cuvitru 200 mg/ml solution for subcutaneous injection | - | - | - | - | [1] 65 65 💬
|
| 188 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 189 | Cyclophosphamide (CY) (Plan 1) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [3] 60 60, 65, 285 💬
|
| 190 | Cyclophosphamide (CY) (Plan 2) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [3] 60 60, 65, 285 💬
|
| 191 | Cyclophosphamide (Cytoxan) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 65 65 💬
|
| 192 | Cyclophosphamide Dose Level 1 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
| 193 | Cyclophosphamide Dose Level 2 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
| 194 | Cyclophosphamide Dose Level 3 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
| 195 | Cyclophosphamide Dose Level 4 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
| 196 | Cyclophosphamide post transplant | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 65 65 💬
|
| 197 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [39] 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 198 | Cyclosporine + BCX7353 | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 199 | Cyclosporins | - | - | - | - | [4] 53 53, 60, 65, 222 💬
|
| 200 | CYKLOKAPRON | - | - | - | - | [1] 65 65 💬
|
| 201 | Cyklokapron Tablets | - | - | - | - | [1] 65 65 💬
|
| 202 | Cytarabine | [1] Cytarabine Cytarabine | [2] Cytarabine
Cytarabine
,
Cytarabine hydrochloride
💬
| - | - | [8] 11 11, 13, 14, 25, 34, 49, 60, 65 💬
|
| 203 | DACLIZUMAB | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [10] 13 13, 26, 56, 60, 63, 65, 97, 107, 283, 284 💬
|
| 204 | Danazol | [1] Danazol Danazol | [1] Danazol
Danazol
💬
| [3] AR AR, ESR1, PGR 💬
| [12] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [5] 60 60, 63, 64, 65, 285 💬
|
| 205 | Data collection | - | - | - | - | [1] 65 65 💬
|
| 206 | Daunorubicin | [1] Daunorubicin Daunorubicin | [3] Daunorubicin hydrochloride
Daunorubicin hydrochloride
,
Daunorubicin
,
Daunorubicin citrate
💬
| - | - | [1] 65 65 💬
|
| 207 | Deoxycytidine | - | - | - | - | [1] 65 65 💬
|
| 208 | Deoxythymidine | - | - | - | - | [1] 65 65 💬
|
| 209 | Deucrictibant | [1] Deucrictibant Deucrictibant | [1] Deucrictibant
Deucrictibant
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 210 | Deucrictibant 20 mg capsule | [1] Deucrictibant Deucrictibant | [1] Deucrictibant
Deucrictibant
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 211 | Deucrictibant high dose | [1] Deucrictibant Deucrictibant | [1] Deucrictibant
Deucrictibant
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 212 | Deucrictibant low dose | [1] Deucrictibant Deucrictibant | [1] Deucrictibant
Deucrictibant
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 213 | Deucrictibant XR tablet | [1] Deucrictibant Deucrictibant | [1] Deucrictibant
Deucrictibant
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 214 | Dexametasone Fosfato Sodico | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 215 | Dexamethasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [29] 13 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
|
| 216 | DEXAMETHASONE SODIUM PHOSPHATE | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 65 65, 70, 96 💬
|
| 217 | Dexamethasone sodium phosphate (soluzione 25mg/ml) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 218 | DEXAMETHASONE SODIUM PHOSPHATE PH. EUR. | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 219 | Dexamethasone, procarbazine | [2] Dexamethasone Dexamethasone, Procarbazine | [5] Dexamethasone
Dexamethasone
,
Procarbazine hydrochloride
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
,
Procarbazine
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 220 | Dextrose, 5% in Water | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 65 65 💬
|
| 221 | Diagnostic Test: A. Routine .1CBC with blood film. .2Liver Function Test. .3Kidney Function Test. 4. Inflamatory marker ESR, CRP B.Immunology 1-Immunoglobulins IgG, IgM, IgA, IgE 2-Flow cytometric assessment: B | - | - | - | - | [1] 65 65 💬
|
| 222 | Diagnostic Test: ataxia score | - | - | - | - | [1] 65 65 💬
|
| 223 | Diagnostic Test: bioelectrical impedance analysis | - | - | - | - | [2] 65 65, 172 💬
|
| 224 | Diagnostic Test: Blood draw | - | - | - | - | [8] 34 34, 65, 85, 86, 96, 97, 240, 299 💬
|
| 225 | Diagnostic Test: blood drawing in healthy controls | - | - | - | - | [1] 65 65 💬
|
| 226 | Diagnostic Test: blood drawing in patients with WAS | - | - | - | - | [1] 65 65 💬
|
| 227 | Diagnostic Test: Blood sampling | - | - | - | - | [8] 49 49, 51, 65, 74, 97, 127, 231, 299 💬
|
| 228 | Diagnostic Test: Five-Times-Sit-to-Stand Test | - | - | - | - | [1] 65 65 💬
|
| 229 | Diagnostic Test: functional and antigenic C1 inhibitor | - | - | - | - | [1] 65 65 💬
|
| 230 | Diagnostic Test: Inborn errors of immunity | - | - | - | - | [1] 65 65 💬
|
| 231 | Diagnostic Test: Magnetic Resonance Imaging and an optional blood test | - | - | - | - | [1] 65 65 💬
|
| 232 | Diagnostic Test: Oral Glucose Tolerance Test | - | - | - | - | [6] 6 6, 13, 57, 65, 77, 299 💬
|
| 233 | Diagnostic Test: Technochrom C1-INH Kit | - | - | - | - | [1] 65 65 💬
|
| 234 | Diagnostic Test: transient elastography (FibroScan) | - | - | - | - | [1] 65 65 💬
|
| 235 | Digoxin | [1] Digoxin Digoxin | [1] Digoxin
Digoxin
💬
| [4] ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬
| [19] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 2 2, 8, 46, 57, 65, 67, 210 💬
|
| 236 | Direct intravenous injection of ivlv-X1 lentiviral vector | - | - | - | - | [1] 65 65 💬
|
| 237 | Donidalorsen | [1] Donidalorsen Donidalorsen | [1] Donidalorsen sodium
Donidalorsen sodium
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 238 | DonidalorsenCAS Number: 2304701-45-7Current Sponsor code: ISIS 721744Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 100mg/mL-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Subcutaneous use | - | - | - | - | [1] 65 65 💬
|
| 239 | Donor mobilized PBSC infusion | - | - | - | - | [3] 60 60, 65, 285 💬
|
| 240 | Donor peripheral blood stem cells. | - | - | - | - | [1] 65 65 💬
|
| 241 | Doxorubicin | [1] Doxorubicin Doxorubicin | [2] Doxorubicin hydrochloride
Doxorubicin hydrochloride
,
Doxorubicin
💬
| - | - | [6] 26 26, 28, 34, 65, 299, 331 💬
|
| 242 | Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase | [3] Cyclophosphamide Cyclophosphamide, Doxorubicin, Methotrexate | [6] Methotrexate
Methotrexate
,
Cyclophosphamide
,
Doxorubicin hydrochloride
,
Methotrexate sodium
,
Doxorubicin
,
Cyclophosphamide
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 65 65 💬
|
| 243 | Drug: KVD900 300 mg | - | - | - | - | [1] 65 65 💬
|
| 244 | DX-2930 | - | - | - | - | [1] 65 65 💬
|
| 245 | DX-2930 - 150mg/4wk | - | - | - | - | [1] 65 65 💬
|
| 246 | DX-2930 - 300mg/2wk | - | - | - | - | [1] 65 65 💬
|
| 247 | DX-2930 - 300mg/4wk | - | - | - | - | [1] 65 65 💬
|
| 248 | DX-88 | - | - | - | - | [1] 65 65 💬
|
| 249 | DX-88 (ecallantide) | [1] Ecallantide Ecallantide | [1] Ecallantide
Ecallantide
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 250 | DX-88 ecallantide | [1] Ecallantide Ecallantide | [1] Ecallantide
Ecallantide
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 251 | DX2930 | - | - | - | - | [1] 65 65 💬
|
| 252 | Ecallantide | [1] Ecallantide Ecallantide | [1] Ecallantide
Ecallantide
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 253 | Ecallantide subcutaneous dosing | [1] Ecallantide Ecallantide | [1] Ecallantide
Ecallantide
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 254 | Echocardiography | - | - | - | - | [6] 28 28, 60, 62, 65, 284, 286 💬
|
| 255 | Efficacy of Gammagard subcutaneously at Week 12 | - | - | - | - | [1] 65 65 💬
|
| 256 | Efficacy of Gammagard subcutaneously at Week 24 | - | - | - | - | [1] 65 65 💬
|
| 257 | Efficacy of Gammagard subcutaneously at Week 36 | - | - | - | - | [1] 65 65 💬
|
| 258 | Efficacy of Gammagard subdermally at Week 12 | - | - | - | - | [1] 65 65 💬
|
| 259 | Efficacy of Gammagard subdermally at Week 24 | - | - | - | - | [1] 65 65 💬
|
| 260 | Efficacy of Gammagard subdermally at Week 36 | - | - | - | - | [1] 65 65 💬
|
| 261 | Elapegademase | [1] Elapegademase Elapegademase | [1] Elapegademase
Elapegademase
💬
| [1] ADA ADA 💬
| [2] Primary immunodeficiency Primary immunodeficiency, Purine metabolism 💬 | [1] 65 65 💬
|
| 262 | Elapegademase-lvlr | [1] Elapegademase Elapegademase | [1] Elapegademase
Elapegademase
💬
| [1] ADA ADA 💬
| [2] Primary immunodeficiency Primary immunodeficiency, Purine metabolism 💬 | [1] 65 65 💬
|
| 263 | ELTROMBOPAG | [1] Eltrombopag Eltrombopag | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [5] 60 60, 63, 65, 284, 285 💬
|
| 264 | Emapalumab | [1] Emapalumab Emapalumab | [1] Emapalumab
Emapalumab
💬
| [1] IFNG IFNG 💬
| [32] African trypanosomiasis African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [6] 49 49, 50, 54, 60, 65, 107 💬
|
| 265 | Emapalumab-Izsg | [1] Emapalumab Emapalumab | [1] Emapalumab
Emapalumab
💬
| [1] IFNG IFNG 💬
| [32] African trypanosomiasis African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 65 65 💬
|
| 266 | Empagliflozin | [1] Empagliflozin Empagliflozin | [1] Empagliflozin
Empagliflozin
💬
| - | - | [17] 28 28, 46, 57, 58, 65, 67, 72, 77, 86, 96, 97, 113, 222, 223, 257, 298, 299 💬
|
| 267 | EP2006 | - | - | - | - | [1] 65 65 💬
|
| 268 | EP2006 (Filgrastim) | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 65 65 💬
|
| 269 | EryDex High dose DSP | - | - | - | - | [1] 65 65 💬
|
| 270 | EryDex Low dose DSP | - | - | - | - | [1] 65 65 💬
|
| 271 | Estradiol | [1] Estradiol Estradiol | [2] Estradiol
Estradiol
,
Estradiol hemihydrate
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [9] 13 13, 46, 49, 65, 76, 78, 118, 226, 299 💬
|
| 272 | Estradiol valerate | [2] Estradiol Estradiol, Estradiol valerate | [3] Estradiol
Estradiol
,
Estradiol valerate
,
Estradiol hemihydrate
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1] 65 65 💬
|
| 273 | Estradiolvalerat | - | - | - | - | [1] 65 65 💬
|
| 274 | Etoposide | [1] Etoposide Etoposide | [2] Etoposide
Etoposide
,
Etoposide phosphate
💬
| - | - | [12] 11 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
|
| 275 | Etoposide, cytarabine, mercaptopurine | [3] Cytarabine Cytarabine, Etoposide, Mercaptopurine | [6] Etoposide
Etoposide
,
Mercaptopurine
,
Cytarabine
,
Cytarabine hydrochloride
,
Etoposide phosphate
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [1] 65 65 💬
|
| 276 | Ex vivo culture and transduction of the patient's autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL20- 4i-EF1alpha-hgammac-OPT vector | - | - | - | - | [1] 65 65 💬
|
| 277 | Exemestane | [1] Exemestane Exemestane | [1] Exemestane
Exemestane
💬
| [1] CYP19A1 CYP19A1 💬
| [2] Ovarian steroidogenesis Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | [1] 65 65 💬
|
| 278 | EZN-2279 | - | - | - | - | [1] 65 65 💬
|
| 279 | Factor XIIa antagonist monoclonal antibody | - | - | - | - | [2] 65 65, 85 💬
|
| 280 | Factor XIIa inhibitor monoclonal antibody | - | - | - | - | [1] 65 65 💬
|
| 281 | Fansidar (pyrimethamine and sulfadoxine) | [2] Pyrimethamine Pyrimethamine, Sulfadoxine | [2] Pyrimethamine
Pyrimethamine
,
Sulfadoxine
💬
| - | - | [1] 65 65 💬
|
| 282 | Fibrinogen (coagulation factorI) | - | - | - | - | [1] 65 65 💬
|
| 283 | Fibrinogen Concentrate from Human Plasma | - | - | - | - | [1] 65 65 💬
|
| 284 | Filgrastim | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [30] 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 285 | Filgrastim Hexal | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 65 65 💬
|
| 286 | FIRAZYR | - | - | - | - | [1] 65 65 💬
|
| 287 | Firazyr (icatibant) 30 mg solution for injection in pre filled syringe | [1] Icatibant Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 288 | FIRAZYR 30 mg solución inyectable en jeringa precargada | - | - | - | - | [1] 65 65 💬
|
| 289 | Firazyr 30 mg solution for injection in pre-filled syringe | - | - | - | - | [1] 65 65 💬
|
| 290 | FIRAZYR*SC 1SIR 30MG 3ML10MG/M | - | - | - | - | [1] 65 65 💬
|
| 291 | Firazyr® 30 mg subcutaneous injection Syringe: 3.0 mL×1 Syringe | - | - | - | - | [1] 65 65 💬
|
| 292 | Fisetin | [1] Fisetin Fisetin | - | - | - | [1] 65 65 💬
|
| 293 | Flebogamma 5% DIF | - | - | - | - | [1] 65 65 💬
|
| 294 | FLUDARABINA | - | - | - | - | [1] 65 65 💬
|
| 295 | Fludarabina Accord | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 65 65 💬
|
| 296 | FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML | - | - | - | - | [1] 65 65 💬
|
| 297 | Fludarabine | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [30] 11 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
|
| 298 | Fludarabine (FLU) | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [3] 60 60, 65, 285 💬
|
| 299 | Fludarabine monophosphate | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [3] 65 65, 284, 326 💬
|
| 300 | Fludarabine phosphate | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [14] 28 28, 36, 49, 51, 60, 61, 62, 63, 65, 96, 283, 284, 285, 286 💬
|
| 301 | Fludarabine phosphate 30 mg | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 164 💬
|
| 302 | Fludarabine phosphate 40 mg | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 164 💬
|
| 303 | Fludarabine, Busulfan, Thymoglobulin | [2] Busulfan Busulfan, Fludarabine | [3] Busulfan
Busulfan
,
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 65 65 💬
|
| 304 | Fludarabine, Melphalan, Thiotepa | [3] Fludarabine Fludarabine, Melphalan, Thiotepa | [5] Melphalan
Melphalan
,
Thiotepa
,
Fludarabine phosphate
,
Fludarabine
,
Melphalan hydrochloride
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 65 65 💬
|
| 305 | Fucose | [1] Fucose Fucose | [1] Elfucose
Elfucose
💬
| - | - | [2] 65 65, 248 💬
|
| 306 | FXIIa inhibitor monoclonal antibody | - | - | - | - | [2] 65 65, 85 💬
|
| 307 | G-CSF | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [12] 6 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
|
| 308 | G-CSF for Conditioning before HSCT. | - | - | - | - | [1] 65 65 💬
|
| 309 | G1XCG | - | - | - | - | [1] 65 65 💬
|
| 310 | G1XCGD transduced CD34+ cells | - | - | - | - | [1] 65 65 💬
|
| 311 | Gadolinium | [1] Gadolinium Gadolinium | - | - | - | [8] 13 13, 34, 46, 65, 77, 86, 113, 305 💬
|
| 312 | Gadolinium For abdomen | [1] Gadolinium Gadolinium | - | - | - | [1] 65 65 💬
|
| 313 | Gadolinium For lower back | [1] Gadolinium Gadolinium | - | - | - | [1] 65 65 💬
|
| 314 | GAMMAGARD LIQUID | - | - | - | - | [1] 65 65 💬
|
| 315 | Gammagard S/D (Solvent/Detergent) | - | - | - | - | [1] 65 65 💬
|
| 316 | Gammaglobulin | - | - | - | - | [1] 65 65 💬
|
| 317 | Gammanorm | - | - | - | - | [2] 14 14, 65 💬
|
| 318 | Gammanorm 165 mg/mL | - | - | - | - | [1] 65 65 💬
|
| 319 | Gammaplex | - | - | - | - | [2] 63 63, 65 💬
|
| 320 | Gammaplex (5%) | - | - | - | - | [1] 65 65 💬
|
| 321 | Gammaplex (Intravenous immunoglobulin) | - | - | - | - | [1] 65 65 💬
|
| 322 | Gammaplex 10 | - | - | - | - | [1] 65 65 💬
|
| 323 | Gamunex-C | - | - | - | - | [2] 14 14, 65 💬
|
| 324 | Garadacimab | [1] Garadacimab Garadacimab | [1] Garadacimab
Garadacimab
💬
| [1] F12 F12 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [2] 65 65, 85 💬
|
| 325 | Gcsf | - | - | - | - | [1] 65 65 💬
|
| 326 | Gene Therapy Method for CGD | - | - | - | - | [1] 65 65 💬
|
| 327 | Gene-Transduced Autologous CD34+ Stem Cells | - | - | - | - | [1] 65 65 💬
|
| 328 | Genetic: Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene | - | - | - | - | [1] 65 65 💬
|
| 329 | Genetic: Autologous CD34+ cells transduced with WASP lentiviral vector | - | - | - | - | [1] 65 65 💬
|
| 330 | Genetic: CL20-i4-EF1a-h?c-OPT | - | - | - | - | [1] 65 65 💬
|
| 331 | Genetic: Dose 1 of BMN 331 | - | - | - | - | [1] 65 65 💬
|
| 332 | Genetic: Dose 2 of BMN 331 | - | - | - | - | [1] 65 65 💬
|
| 333 | Genetic: Dose 3 of BMN 331 | - | - | - | - | [1] 65 65 💬
|
| 334 | Genetic: Dose 4 of BMN 331 | - | - | - | - | [1] 65 65 💬
|
| 335 | Genetic: Dose 5 of BMN 331 | - | - | - | - | [1] 65 65 💬
|
| 336 | Genetic: Dose 6 of BMN 331 | - | - | - | - | [1] 65 65 💬
|
| 337 | Genetic: Dose 7 of BMN 331 | - | - | - | - | [1] 65 65 💬
|
| 338 | Genetic: EN-374 | - | - | - | - | [1] 65 65 💬
|
| 339 | Genetic: ex-vivo gene-therapy | - | - | - | - | [1] 65 65 💬
|
| 340 | Genetic: FACS analyses | - | - | - | - | [1] 65 65 💬
|
| 341 | Genetic: Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101) | - | - | - | - | [1] 65 65 💬
|
| 342 | Genetic: Infusion of autologous EFS-ADA LV CD34+ cells | - | - | - | - | [1] 65 65 💬
|
| 343 | Genetic: Infusion of lentiviral TYF-CGD-modified autologous stem cells | - | - | - | - | [1] 65 65 💬
|
| 344 | Genetic: Lentiviral Gene Transfer | - | - | - | - | [1] 65 65 💬
|
| 345 | Genetic: MUNC-CD34 | - | - | - | - | [1] 65 65 💬
|
| 346 | Genetic: MUNC-T3 | - | - | - | - | [1] 65 65 💬
|
| 347 | Genetic: OTL-103 | - | - | - | - | [1] 65 65 💬
|
| 348 | Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion | - | - | - | - | [1] 65 65 💬
|
| 349 | Genetic: Plerixafor | [1] Plerixafor Plerixafor | [1] Plerixafor
Plerixafor
💬
| [1] CXCR4 CXCR4 💬
| [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 65 65 💬
|
| 350 | Genetic: polymerase chain reaction | - | - | - | - | [4] 28 28, 60, 65, 285 💬
|
| 351 | Genetic: retroviral SF71-gp91phox transduced CD34+ cells | - | - | - | - | [1] 65 65 💬
|
| 352 | Genetic: Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre | - | - | - | - | [1] 65 65 💬
|
| 353 | Genetic: Target Sequencing by NGS ( Next-generation sequencing) | - | - | - | - | [1] 65 65 💬
|
| 354 | Genetic: whole exome sequencing | - | - | - | - | [6] 2 2, 6, 65, 120, 127, 149 💬
|
| 355 | Genetic: X vivo gene therapy | - | - | - | - | [1] 65 65 💬
|
| 356 | Genetically modified autologous blood stem cells | - | - | - | - | [1] 65 65 💬
|
| 357 | Glycosade | - | - | - | - | [3] 65 65, 256, 257 💬
|
| 358 | GNR-038, 100 ??/ kg | - | - | - | - | [1] 65 65 💬
|
| 359 | GNR-038, 100 ??/kg | - | - | - | - | [1] 65 65 💬
|
| 360 | GNR-038, 25 ??/kg | - | - | - | - | [1] 65 65 💬
|
| 361 | GNR-038, 50 ??/ kg | - | - | - | - | [1] 65 65 💬
|
| 362 | GNR-038, 50 ??/kg | - | - | - | - | [1] 65 65 💬
|
| 363 | GNR-038. The dose will be selected according to results of stage 1 clinical trial. | - | - | - | - | [1] 65 65 💬
|
| 364 | Gold | [1] Gold Gold | - | - | - | [71] 2 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
|
| 365 | Gp91 Grans | - | - | - | - | [1] 65 65 💬
|
| 366 | Granulocyte colony stimulating factor (G-CSF) | - | - | - | - | [1] 65 65 💬
|
| 367 | GTG003.08 | - | - | - | - | [1] 65 65 💬
|
| 368 | GTX-102 high dose fast Period 1 and Period 2 | - | - | - | - | [1] 65 65 💬
|
| 369 | GTX-102 low dose fast Period 1 and Period 2 | - | - | - | - | [1] 65 65 💬
|
| 370 | GTX-102 medium dose fast Period 1 and Period 2 | - | - | - | - | [1] 65 65 💬
|
| 371 | GTX-102 medium dose slow Period 1 and Period 2 | - | - | - | - | [1] 65 65 💬
|
| 372 | GVHD Prophylaxis | - | - | - | - | [3] 2 2, 60, 65 💬
|
| 373 | Haemocomplettan P | - | - | - | - | [1] 65 65 💬
|
| 374 | Haemocomplettan(R) P | - | - | - | - | [1] 65 65 💬
|
| 375 | Haemocomplettan(R) P 1g/2g | - | - | - | - | [1] 65 65 💬
|
| 376 | Haploidentical Hematopoietic Cell Transplantation | - | - | - | - | [2] 60 60, 65 💬
|
| 377 | Hematopoetic Stem Cell Transplantation | - | - | - | - | [6] 19 19, 65, 121, 160, 308, 326 💬
|
| 378 | Hematopoietic Stem Cell Transplant | - | - | - | - | [2] 65 65, 285 💬
|
| 379 | Hematopoietic stem cell transplant (HSCT) | - | - | - | - | [1] 65 65 💬
|
| 380 | Hematopoietic Stem Cell Transplantation | - | - | - | - | [13] 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
|
| 381 | Heparin | [1] Heparin Heparin | [2] Heparin sodium
Heparin sodium
,
Heparin calcium
💬
| [1] SERPINC1 SERPINC1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [15] 47 47, 48, 60, 65, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317, 344 💬
|
| 382 | Higher-volume C1-esterase inhibitor | - | - | - | - | [1] 65 65 💬
|
| 383 | Hizentra | - | - | - | - | [4] 14 14, 50, 51, 65 💬
|
| 384 | Hizentra® | - | - | - | - | [2] 14 14, 65 💬
|
| 385 | Hu-G012267 | - | - | - | - | [1] 65 65 💬
|
| 386 | HUMAN FIBRINOGEN | - | - | - | - | [1] 65 65 💬
|
| 387 | Human Fibrinogen Concentrate | - | - | - | - | [1] 65 65 💬
|
| 388 | Human Immunglobulin G (IgG) | - | - | - | - | [1] 65 65 💬
|
| 389 | Human Immunoglobulin | - | - | - | - | [2] 63 63, 65 💬
|
| 390 | HUMAN IMMUNOGLOBULIN G | [1] Human immunoglobulin G Human immunoglobulin G | [1] Globulin, immune
Globulin, immune
💬
| - | - | [4] 14 14, 50, 63, 65 💬
|
| 391 | Human normal immunoglobulin | - | - | - | - | [6] 13 13, 14, 50, 51, 63, 65 💬
|
| 392 | HUMAN NORMAL IMMUNOGLOBULIN (IV) | - | - | - | - | [4] 11 11, 14, 63, 65 💬
|
| 393 | Human normal immunoglobulin (IVIg) | - | - | - | - | [3] 14 14, 50, 65 💬
|
| 394 | Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin) | - | - | - | - | [1] 65 65 💬
|
| 395 | Human normal immunoglobulin (subcutaneous) | - | - | - | - | [1] 65 65 💬
|
| 396 | HUMAN NORMAL IMMUNOGLOBULIN FOR | - | - | - | - | [1] 65 65 💬
|
| 397 | Human normal immunoglobulin for intravenous administration | - | - | - | - | [3] 14 14, 51, 65 💬
|
| 398 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE | - | - | - | - | [2] 63 63, 65 💬
|
| 399 | Human normal immunoglobulin for intravenous use (IVIG) | - | - | - | - | [1] 65 65 💬
|
| 400 | Human normal immunoglobulin for subcutaneous administration | - | - | - | - | [2] 51 51, 65 💬
|
| 401 | Human Normal Immunoglobulin for Subcutaneous Administration (IGSC) | - | - | - | - | [1] 65 65 💬
|
| 402 | Human normal immunoglobulin G (IgG > 98% purity) | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 403 | Hyaluronidase | [1] Hyaluronidase Hyaluronidase | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| - | - | [7] 13 13, 14, 28, 51, 60, 65, 331 💬
|
| 404 | Hydroxyurea | [1] Hydroxyurea Hydroxyurea | [1] Hydroxyurea
Hydroxyurea
💬
| [1] RRM2 RRM2 💬
| [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | [10] 3 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
|
| 405 | HYQVIA | - | - | - | - | [2] 14 14, 65 💬
|
| 406 | HyQvia 100 mg/ml solution for infusion for subcutaneous use | - | - | - | - | [2] 14 14, 65 💬
|
| 407 | I.v. recombinant human C1 inhibitor | - | - | - | - | [1] 65 65 💬
|
| 408 | I10E | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 409 | IB 1001 | - | - | - | - | [1] 65 65 💬
|
| 410 | IB1001 | - | - | - | - | [2] 19 19, 65 💬
|
| 411 | Ibuprofen | [1] Ibuprofen Ibuprofen | [5] Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [8] 13 13, 46, 65, 96, 107, 113, 271, 299 💬
|
| 412 | ICaspase9-transduced T cells | - | - | - | - | [1] 65 65 💬
|
| 413 | ICATIBANT | [1] Icatibant Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 414 | Icatibant (30 mg) | [1] Icatibant Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 415 | ICATIBANT ACETATE | [2] Acetate Acetate, Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 416 | Icatibant Acetate (JAN) | [2] Acetate Acetate, Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 417 | Icatibant acetate solution for injection 10 mg/ml | [2] Acetate Acetate, Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 418 | Icatibant Injection (Icanticure®) | [1] Icatibant Icatibant | [1] Icatibant acetate
Icatibant acetate
💬
| [1] BDKRB2 BDKRB2 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 419 | IFN-gamma | - | - | - | - | [1] 65 65 💬
|
| 420 | Ig VENA 50 g/l solution for infusion 100 ml vial + infusion set | - | - | - | - | [2] 63 63, 65 💬
|
| 421 | IgG Next Generation | - | - | - | - | [2] 63 63, 65 💬
|
| 422 | IgG Next Generation (BT595) | - | - | - | - | [1] 65 65 💬
|
| 423 | IgHy10 | - | - | - | - | [1] 65 65 💬
|
| 424 | IGIV, 10% | - | - | - | - | [2] 14 14, 65 💬
|
| 425 | IGIV-C 10% | - | - | - | - | [1] 65 65 💬
|
| 426 | IgNextGen 16% | - | - | - | - | [1] 65 65 💬
|
| 427 | IGNG | - | - | - | - | [1] 65 65 💬
|
| 428 | IgPro | - | - | - | - | [1] 65 65 💬
|
| 429 | IgPro10 | - | - | - | - | [4] 14 14, 51, 63, 65 💬
|
| 430 | IgPro20 | - | - | - | - | [4] 14 14, 50, 51, 65 💬
|
| 431 | IGSC 20% | - | - | - | - | [1] 65 65 💬
|
| 432 | IGSC 20% 150 mg/kg | - | - | - | - | [1] 65 65 💬
|
| 433 | IGSC 20% daily push versus 2 times per week pump | - | - | - | - | [1] 65 65 💬
|
| 434 | IGSC 20% daily push versus every 2 weeks pump | - | - | - | - | [1] 65 65 💬
|
| 435 | IGSC 20% daily push versus once a week pump | - | - | - | - | [1] 65 65 💬
|
| 436 | IGSC 20% infusion | - | - | - | - | [1] 65 65 💬
|
| 437 | IGSC, 16% | - | - | - | - | [1] 65 65 💬
|
| 438 | IGSC, 20% | - | - | - | - | [1] 65 65 💬
|
| 439 | Immune Globulin Infusion (Human), 10% | - | - | - | - | [1] 65 65 💬
|
| 440 | Immune Globulin Intravenous | - | - | - | - | [1] 65 65 💬
|
| 441 | Immune Globulin Intravenous (Human) | - | - | - | - | [2] 50 50, 65 💬
|
| 442 | Immune Globulin Intravenous (Human) 5% Liquid, IVIG-SN™ | - | - | - | - | [1] 65 65 💬
|
| 443 | Immune Globulin Intravenous (human), 10% | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 444 | Immune Globulin Intravenous (Human), 10% Solution | - | - | - | - | [1] 65 65 💬
|
| 445 | Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution | - | - | - | - | [1] 65 65 💬
|
| 446 | Immune Globulin Intravenous (IGIV) | - | - | - | - | [1] 65 65 💬
|
| 447 | Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified | - | - | - | - | [1] 65 65 💬
|
| 448 | Immune Globulin Subcutaneos, 20% | - | - | - | - | [1] 65 65 💬
|
| 449 | Immune Globulin Subcutaneous (Human) | - | - | - | - | [2] 14 14, 65 💬
|
| 450 | Immune Globulin Subcutaneous (Human) (SCIG) | - | - | - | - | [1] 65 65 💬
|
| 451 | Immune Globulin Subcutaneous (Human), 20% | - | - | - | - | [1] 65 65 💬
|
| 452 | Immune Globulin Subcutaneous (Human), 20% Caprylate/Chromatography Purified (IGSC 20%) | - | - | - | - | [1] 65 65 💬
|
| 453 | Immune Globulin Subcutaneous (Human), 20% Solution | - | - | - | - | [1] 65 65 💬
|
| 454 | Immune Globulin Subcutaneous (Human), 20%, Caprylate/Chromatography Purified | - | - | - | - | [1] 65 65 💬
|
| 455 | Immune Globulin Subcutaneous, 20% | - | - | - | - | [1] 65 65 💬
|
| 456 | Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%) | - | - | - | - | [1] 65 65 💬
|
| 457 | Immunglobulin (human) | - | - | - | - | [1] 65 65 💬
|
| 458 | IMMUNOGLOBULIN G | - | - | - | - | [9] 2 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
|
| 459 | Immunoglobulin G (Ig NextGen 16%) | - | - | - | - | [1] 65 65 💬
|
| 460 | Immunoglobulin Intravenous (Human) | - | - | - | - | [2] 63 63, 65 💬
|
| 461 | IMMUNOGLOBULINA UMANA NORMALE | - | - | - | - | [4] 14 14, 51, 63, 65 💬
|
| 462 | Immunoglobulins Intravenous (Human) | - | - | - | - | [1] 65 65 💬
|
| 463 | Immunoglobulins, normal human | - | - | - | - | [1] 65 65 💬
|
| 464 | Immunological diagnosis tests | - | - | - | - | [1] 65 65 💬
|
| 465 | Immunosuppression Only Conditioning | - | - | - | - | [1] 65 65 💬
|
| 466 | Immunosuppression Only Conditioning -Closed with amendment L | - | - | - | - | [1] 65 65 💬
|
| 467 | In vitro-treated peripheral blood stem cell transplantation | - | - | - | - | [2] 60 60, 65 💬
|
| 468 | Increlex | - | - | - | - | [2] 65 65, 96 💬
|
| 469 | Infliximab | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
|
| 470 | INHIBIDOR DE LA ESTERASA C1 COMPLEMENTO | - | - | - | - | [1] 65 65 💬
|
| 471 | Interferon Gamma | [1] Interferon Gamma Interferon Gamma | - | - | - | [9] 18 18, 65, 85, 96, 107, 228, 299, 301, 326 💬
|
| 472 | INTERFERON GAMMA-1B | [2] Interferon Gamma Interferon Gamma, Interferon gamma-1b | [1] Interferon gamma-1b
Interferon gamma-1b
💬
| [2] IFNGR1 IFNGR1, IFNGR2 💬
| [18] Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | [7] 18 18, 65, 85, 228, 299, 301, 326 💬
|
| 473 | Interferon-gamma | - | - | - | - | [1] 65 65 💬
|
| 474 | Interleukin-2 | - | - | - | - | [6] 2 2, 13, 49, 50, 55, 65 💬
|
| 475 | Intratect | - | - | - | - | [4] 13 13, 14, 35, 65 💬
|
| 476 | Intravenous immunoglobulin (IVIg) | - | - | - | - | [8] 14 14, 17, 19, 63, 65, 85, 164, 296 💬
|
| 477 | Intravenous immunoglobulin infusion | - | - | - | - | [1] 65 65 💬
|
| 478 | Intravenous infusion of transduced cells | - | - | - | - | [1] 65 65 💬
|
| 479 | ISIS 721744 | - | - | - | - | [1] 65 65 💬
|
| 480 | ISIS 721744Pharmaceutical Form: Solution for injection | - | - | - | - | [1] 65 65 💬
|
| 481 | Isolex 300i Magnetic Cell Selector | - | - | - | - | [1] 65 65 💬
|
| 482 | Itraconazole | [1] Itraconazole Itraconazole | [1] Itraconazole
Itraconazole
💬
| - | - | [13] 2 2, 3, 6, 46, 65, 67, 96, 97, 137, 158, 227, 299, 309 💬
|
| 483 | IV treatment with IGSC, 10% | - | - | - | - | [1] 65 65 💬
|
| 484 | IVIG | - | - | - | - | [8] 11 11, 13, 14, 18, 51, 63, 65, 172 💬
|
| 485 | IVIG-Immuglo | - | - | - | - | [1] 65 65 💬
|
| 486 | IVIG-PEG | - | - | - | - | [1] 65 65 💬
|
| 487 | IVIG-VImmune | - | - | - | - | [1] 65 65 💬
|
| 488 | Jardiance | - | - | - | - | [2] 65 65, 86 💬
|
| 489 | JE049 | - | - | - | - | [1] 65 65 💬
|
| 490 | JSP191 | - | - | - | - | [2] 65 65, 285 💬
|
| 491 | Kedrion IVIG 10% | - | - | - | - | [2] 63 63, 65 💬
|
| 492 | KIg10 | - | - | - | - | [1] 65 65 💬
|
| 493 | KINERET | - | - | - | - | [8] 41 41, 49, 54, 57, 65, 106, 266, 299 💬
|
| 494 | KIOVIG | - | - | - | - | [2] 14 14, 65 💬
|
| 495 | KIOVIG 100 mg/ml solution for infusion | - | - | - | - | [2] 14 14, 65 💬
|
| 496 | KLH | - | - | - | - | [2] 13 13, 65 💬
|
| 497 | Koru 24 G HIgH Flo Subcutaneous Safety Needle Set (investigational in the US) | - | - | - | - | [1] 65 65 💬
|
| 498 | KVD824 | - | - | - | - | [1] 65 65 💬
|
| 499 | KVD824 300 mg Compresse a rilascio modificato | - | - | - | - | [1] 65 65 💬
|
| 500 | KVD824 300 mg Modified Release Tablets | - | - | - | - | [1] 65 65 💬
|
| 501 | KVD824 hydrochloride | - | - | - | - | [1] 65 65 💬
|
| 502 | KVD824 Immediate-Release Capsule | - | - | - | - | [1] 65 65 💬
|
| 503 | KVD824 Prototype 1 modified-release tablet | - | - | - | - | [1] 65 65 💬
|
| 504 | KVD824 Prototype 2 modified-release tablet | - | - | - | - | [1] 65 65 💬
|
| 505 | KVD824 Prototype 3 modified-release tablet | - | - | - | - | [1] 65 65 💬
|
| 506 | KVD900 | - | - | - | - | [1] 65 65 💬
|
| 507 | KVD900 100 mg Film Coated Tablet | - | - | - | - | [1] 65 65 💬
|
| 508 | KVD900 150 mg | - | - | - | - | [1] 65 65 💬
|
| 509 | KVD900 300 mg | - | - | - | - | [1] 65 65 💬
|
| 510 | KVD900 300 mg compressa rivestita con film | - | - | - | - | [1] 65 65 💬
|
| 511 | KVD900 300 mg Film Coated Tablet | - | - | - | - | [1] 65 65 💬
|
| 512 | KVD900 600 mg | - | - | - | - | [1] 65 65 💬
|
| 513 | L-Arginin-hydrochlorid-einmolar Fresenius | - | - | - | - | [1] 65 65 💬
|
| 514 | L-fucose | [1] Fucose Fucose | [1] Elfucose
Elfucose
💬
| - | - | [2] 65 65, 248 💬
|
| 515 | LADICell | - | - | - | - | [1] 65 65 💬
|
| 516 | LANADELUMAB | [1] Lanadelumab Lanadelumab | [1] Lanadelumab
Lanadelumab
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 517 | Lanadelumab 150 mg | [1] Lanadelumab Lanadelumab | [1] Lanadelumab
Lanadelumab
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 518 | Lanadelumab 300 mg | [1] Lanadelumab Lanadelumab | [1] Lanadelumab
Lanadelumab
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 519 | Lapine T-Lymphocyte Immune Globulin | - | - | - | - | [4] 62 62, 65, 284, 286 💬
|
| 520 | Lemtrada | - | - | - | - | [2] 13 13, 65 💬
|
| 521 | Leniolisib | [1] Leniolisib Leniolisib | [2] Leniolisib
Leniolisib
,
Leniolisib phosphate
💬
| [3] PIK3CA PIK3CA, PIK3CB, PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [2] 53 53, 65 💬
|
| 522 | Leniolisib phosphate | [1] Leniolisib Leniolisib | [2] Leniolisib
Leniolisib
,
Leniolisib phosphate
💬
| [3] PIK3CA PIK3CA, PIK3CB, PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 65 65 💬
|
| 523 | Lenograstim | [1] Lenograstim Lenograstim | [1] Lenograstim
Lenograstim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [8] 2 2, 13, 16, 18, 19, 57, 65, 97 💬
|
| 524 | Lentiviral G1XCGD Gene Therapy | - | - | - | - | [1] 65 65 💬
|
| 525 | Lentiviral vector transduced CD34+ cells | - | - | - | - | [1] 65 65 💬
|
| 526 | Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [13] 5 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
|
| 527 | Levacetylleucine | - | - | - | - | [1] 65 65 💬
|
| 528 | LFB-IgSC | - | - | - | - | [1] 65 65 💬
|
| 529 | Low-volume C1-esterase inhibitor | - | - | - | - | [1] 65 65 💬
|
| 530 | Lung function measurement | - | - | - | - | [1] 65 65 💬
|
| 531 | MABCAMPATH | - | - | - | - | [3] 13 13, 60, 65 💬
|
| 532 | Mabthera | - | - | - | - | [20] 11 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
|
| 533 | MABTHERA - 2 FIALE 100 MG 10 ML | - | - | - | - | [2] 19 19, 65 💬
|
| 534 | Magnetic Resonance Imaging | - | - | - | - | [10] 6 6, 13, 19, 22, 28, 34, 65, 205, 285, 299 💬
|
| 535 | MAS825 | [1] MAS825 MAS825 | - | - | - | [1] 65 65 💬
|
| 536 | Mavorixafor | [1] Mavorixafor Mavorixafor | [1] Mavorixafor
Mavorixafor
💬
| [1] CXCR4 CXCR4 💬
| [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 65 65 💬
|
| 537 | MBM-01 | - | - | - | - | [1] 65 65 💬
|
| 538 | MCTLs | - | - | - | - | [1] 65 65 💬
|
| 539 | Melphalan | [1] Melphalan Melphalan | [2] Melphalan
Melphalan
,
Melphalan hydrochloride
💬
| - | - | [19] 11 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
|
| 540 | Mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| [1] HPRT1 HPRT1 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [4] 65 65, 96, 97, 164 💬
|
| 541 | Mesna | [1] Coenzyme M Coenzyme M | [1] Mesna
Mesna
💬
| - | - | [12] 11 11, 13, 16, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
|
| 542 | Messenger RNA encoding Cas9 | - | - | - | - | [1] 65 65 💬
|
| 543 | Metformin | [1] Metformin Metformin | [2] Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| [2] PRKAA1 PRKAA1, PRKAA2 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [31] 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
|
| 544 | Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [41] 11 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 545 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 546 | Methylprednisolone (MP) | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 60 60, 65, 285 💬
|
| 547 | Methylprednisolone or Prednisolone | [2] Methylprednisolone Methylprednisolone, Prednisolone | [3] Methylprednisolone
Methylprednisolone
,
Prednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 💬
|
| 548 | Miltenyi CliniMACS selection system | - | - | - | - | [1] 65 65 💬
|
| 549 | Mozobil | - | - | - | - | [2] 65 65, 285 💬
|
| 550 | MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 24 MG/1.2 ML 1 FLACONCINO | - | - | - | - | [1] 65 65 💬
|
| 551 | Mozobil 20mg/mL vial (injectable solution for subcutaneous use) | - | - | - | - | [1] 65 65 💬
|
| 552 | Mozobil 20mg/mL vial (injectable solution, subcutaneous use) | - | - | - | - | [1] 65 65 💬
|
| 553 | Mozobil, | - | - | - | - | [1] 65 65 💬
|
| 554 | MTP 101-LF | - | - | - | - | [1] 65 65 💬
|
| 555 | Multigated Acquisition Scan | - | - | - | - | [5] 60 60, 62, 65, 284, 286 💬
|
| 556 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [38] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 557 | Mycophenolate mofetil (MMF) | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [8] 13 13, 49, 51, 60, 65, 66, 222, 223 💬
|
| 558 | Myeloablative Conditioning-Closed with amendment L | - | - | - | - | [1] 65 65 💬
|
| 559 | Myeloablative Preparative Regimen | - | - | - | - | [3] 62 62, 65, 284 💬
|
| 560 | MYELOSTIM | - | - | - | - | [1] 65 65 💬
|
| 561 | MYELOSTIM - 34 1 FLACONCINO LIOFILIZZATO 33.6 MIU + SIRINGA PRERIEMPITA SOLVENTE 1 ML | - | - | - | - | [2] 19 19, 65 💬
|
| 562 | MYELOSTIM 34 milions UI/ml - powder and solvent for solution for injection/infusion | - | - | - | - | [1] 65 65 💬
|
| 563 | MYELOSTIM 34 milions UI/ml, powder and solvent for solution for injection or infusion | - | - | - | - | [1] 65 65 💬
|
| 564 | N-Acetyl-L-Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [3] 18 18, 19, 65 💬
|
| 565 | N-Acetyl-L-LeucineProduct Code: IB1001Pharmaceutical Form: Powder and solvent for oral solutionINN or Proposed INN: N-Acetyl-L-leucineOther descriptive name: 2(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACIDConcentration unit: g gram(s)Concentration type: equalConcentration number: 1-Product Name: N-Acetyl-L-LeucineProduct Code: IB1001Pharmaceutical Form: Granules for oral suspension in sachetINN or Proposed INN: N-Acetyl-L-leucineOther descriptive name: 2(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACIDConcentration unit: g gram(s)Concentration type: equalConcentration number: 1- | - | - | - | - | [1] 65 65 💬
|
| 566 | Nanogam 100 mg/ml | - | - | - | - | [1] 65 65 💬
|
| 567 | Nanogam® 50 mg/ml | - | - | - | - | [1] 65 65 💬
|
| 568 | Navenibart | [1] Navenibart Navenibart | [1] Navenibart
Navenibart
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 569 | NDV-3A | - | - | - | - | [1] 65 65 💬
|
| 570 | NewGam | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 571 | Newnorm | - | - | - | - | [1] 65 65 💬
|
| 572 | Nicotinamide | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [19] 2 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
|
| 573 | Nicotinamide riboside | [2] Nicotinamide Nicotinamide, Nicotinamide riboside | [1] Niacinamide
Niacinamide
💬
| - | - | [14] 2 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 97, 191 💬
|
| 574 | None | - | - | - | - | [14] 13 13, 46, 65, 84, 85, 96, 97, 106, 160, 161, 171, 222, 223, 299 💬
|
| 575 | Nonmyeloablative allogeneic hematopoietic stem cell transplantation | - | - | - | - | [6] 28 28, 51, 60, 62, 65, 285 💬
|
| 576 | Normal human immunoglobulin G | [1] Human immunoglobulin G Human immunoglobulin G | [1] Globulin, immune
Globulin, immune
💬
| - | - | [1] 65 65 💬
|
| 577 | Normal Saline IV Administration | - | - | - | - | [1] 65 65 💬
|
| 578 | Norovirus -specific T-cell (NST) therapy | - | - | - | - | [1] 65 65 💬
|
| 579 | Noxafil | - | - | - | - | [2] 65 65, 299 💬
|
| 580 | Noxafil 40 mg/ml oral solution | - | - | - | - | [1] 65 65 💬
|
| 581 | NTLA-2002 | [1] NTLA-2002 NTLA-2002 | - | - | - | [1] 65 65 💬
|
| 582 | NutropinAq 10mg/2ml (30 I.E.) Injektionsllösung | - | - | - | - | [1] 65 65 💬
|
| 583 | OCTA-C1-INH | - | - | - | - | [1] 65 65 💬
|
| 584 | Octagam | - | - | - | - | [2] 13 13, 65 💬
|
| 585 | Octagam 10% | - | - | - | - | [3] 50 50, 63, 65 💬
|
| 586 | Octagam 5% | - | - | - | - | [2] 13 13, 65 💬
|
| 587 | OCTAGAM 50 mg/ml oldatos infúzió | - | - | - | - | [1] 65 65 💬
|
| 588 | Octanorm | - | - | - | - | [2] 50 50, 65 💬
|
| 589 | Octanorm 16.5% | - | - | - | - | [2] 50 50, 65 💬
|
| 590 | OMALIZUMAB | [1] Omalizumab Omalizumab | [1] Omalizumab
Omalizumab
💬
| [1] FCER1A FCER1A 💬
| [4] Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | [7] 46 46, 53, 65, 98, 162, 226, 299 💬
|
| 591 | Omalizumab (Xolair) | [1] Omalizumab Omalizumab | [1] Omalizumab
Omalizumab
💬
| [1] FCER1A FCER1A 💬
| [4] Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | [1] 65 65 💬
|
| 592 | ORENCIA | - | - | - | - | [16] 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 223, 271, 300 💬
|
| 593 | ORENCIA® 125 mg solution for injection in pre-filled syringe | - | - | - | - | [1] 65 65 💬
|
| 594 | Orladeyo | - | - | - | - | [1] 65 65 💬
|
| 595 | Other hematological Agents | - | - | - | - | [1] 65 65 💬
|
| 596 | Other: | - | - | - | - | [3] 2 2, 6, 65 💬
|
| 597 | Other: 0.9% sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 65 65 💬
|
| 598 | Other: Blood sample | - | - | - | - | [37] 2 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
|
| 599 | Other: Blood sampling for Laboratory Developed Test (LDT) analysis | - | - | - | - | [1] 65 65 💬
|
| 600 | Other: Blood test | - | - | - | - | [11] 10 10, 19, 46, 51, 57, 65, 66, 83, 86, 96, 113 💬
|
| 601 | Other: chest CT scan | - | - | - | - | [1] 65 65 💬
|
| 602 | Other: Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation | - | - | - | - | [1] 65 65 💬
|
| 603 | Other: Cultured Thymus Tissue Implantation with Parathyroid Transplantation | - | - | - | - | [1] 65 65 💬
|
| 604 | Other: flow cytometry | - | - | - | - | [5] 28 28, 51, 60, 65, 285 💬
|
| 605 | Other: Food Diary | - | - | - | - | [1] 65 65 💬
|
| 606 | Other: Haematopoietic Stem Cell Transplantation (HSCT) | - | - | - | - | [1] 65 65 💬
|
| 607 | Other: immunologic technique | - | - | - | - | [3] 49 49, 65, 285 💬
|
| 608 | Other: Laboratory Biomarker Analysis | - | - | - | - | [22] 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
| 609 | Other: Lactate Meter | - | - | - | - | [2] 65 65, 257 💬
|
| 610 | Other: Medical History Questionnaires | - | - | - | - | [1] 65 65 💬
|
| 611 | Other: Modified Mixed Meal Tolerance Test | - | - | - | - | [1] 65 65 💬
|
| 612 | Other: Modified Oral Glucose Tolerance Test | - | - | - | - | [1] 65 65 💬
|
| 613 | Other: Normal Saline IV Administration | - | - | - | - | [1] 65 65 💬
|
| 614 | Other: Palliative Care | - | - | - | - | [6] 19 19, 65, 121, 160, 308, 326 💬
|
| 615 | Other: pCCLChimGp91lentiviral vector containing the human gp91 phox (CYBB) gene | - | - | - | - | [1] 65 65 💬
|
| 616 | Other: Quality-of-Life Assessment | - | - | - | - | [9] 34 34, 36, 51, 62, 65, 96, 284, 286, 298 💬
|
| 617 | OTL-101 | - | - | - | - | [1] 65 65 💬
|
| 618 | OTL-103 | - | - | - | - | [1] 65 65 💬
|
| 619 | OTL-103 Dispersion for Infusion | - | - | - | - | [1] 65 65 💬
|
| 620 | Ovastat 1000 | [1] Treosulfan Treosulfan | [1] Treosulfan
Treosulfan
💬
| - | - | [2] 13 13, 65 💬
|
| 621 | Ovastat 1000 (Treosulfan injection) | [1] Treosulfan Treosulfan | [1] Treosulfan
Treosulfan
💬
| - | - | [1] 65 65 💬
|
| 622 | Ovastat 1000 mg, powder for solution for infusion | [1] Treosulfan Treosulfan | [1] Treosulfan
Treosulfan
💬
| - | - | [1] 65 65 💬
|
| 623 | Ovastat 5000 | [1] Treosulfan Treosulfan | [1] Treosulfan
Treosulfan
💬
| - | - | [2] 13 13, 65 💬
|
| 624 | Ovastat 5000 (Treosulfan injection) | [1] Treosulfan Treosulfan | [1] Treosulfan
Treosulfan
💬
| - | - | [1] 65 65 💬
|
| 625 | Ovastat 5000 mg, powder for solution for infusion | [1] Treosulfan Treosulfan | [1] Treosulfan
Treosulfan
💬
| - | - | [1] 65 65 💬
|
| 626 | Palifermin | [1] Palifermin Palifermin | [1] Palifermin
Palifermin
💬
| [1] FGFR2 FGFR2 💬
| [12] Calcium signaling pathway Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬 | [6] 13 13, 36, 38, 39, 65, 96 💬
|
| 627 | Pantoprazole | [1] Pantoprazole Pantoprazole | [2] Pantoprazole sodium
Pantoprazole sodium
,
Pantoprazole
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [2] 13 13, 65 💬
|
| 628 | Pantoprazolo 20 mg gastro-resistant tablets | - | - | - | - | [1] 65 65 💬
|
| 629 | Peg-Ada | - | - | - | - | [1] 65 65 💬
|
| 630 | PEG-interleukin-2 | [1] PEG-interleukin-2 PEG-interleukin-2 | - | - | - | [1] 65 65 💬
|
| 631 | Peripheral Blood Stem Cell Transplantation | - | - | - | - | [12] 11 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
|
| 632 | Peripheral Blood Stem Cells | - | - | - | - | [2] 51 51, 65 💬
|
| 633 | PHA-022121 | - | - | - | - | [1] 65 65 💬
|
| 634 | PHA-022121 Monohydrate | - | - | - | - | [1] 65 65 💬
|
| 635 | Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells | - | - | - | - | [1] 65 65 💬
|
| 636 | Pheripheral blood stem cells | - | - | - | - | [1] 65 65 💬
|
| 637 | Phosphate Buffer Saline (PBS), | - | - | - | - | [1] 65 65 💬
|
| 638 | Phosphate Buffer Saline (PBS), pH 7.0 | - | - | - | - | [1] 65 65 💬
|
| 639 | PHVS416 | - | - | - | - | [1] 65 65 💬
|
| 640 | Pioglitazone | [1] Pioglitazone Pioglitazone | [2] Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| [1] PPARG PPARG 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [17] 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
|
| 641 | PLERIXAFOR | [1] Plerixafor Plerixafor | [1] Plerixafor
Plerixafor
💬
| [1] CXCR4 CXCR4 💬
| [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [5] 20 20, 51, 65, 285, 299 💬
|
| 642 | Plerixafor for Conditioning before HSCT. | [1] Plerixafor Plerixafor | [1] Plerixafor
Plerixafor
💬
| [1] CXCR4 CXCR4 💬
| [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 65 65 💬
|
| 643 | PM359 | - | - | - | - | [1] 65 65 💬
|
| 644 | PnCJ PPS | - | - | - | - | [1] 65 65 💬
|
| 645 | PNEUMO 23 | - | - | - | - | [2] 65 65, 97 💬
|
| 646 | Pneumovax® (pneumococcal polysaccharide vaccine) | - | - | - | - | [1] 65 65 💬
|
| 647 | Polyclonal IgG | - | - | - | - | [1] 65 65 💬
|
| 648 | Posaconazole | [1] Posaconazole Posaconazole | [1] Posaconazole
Posaconazole
💬
| - | - | [4] 60 60, 65, 96, 299 💬
|
| 649 | Posaconazole (PSZ) | [1] Posaconazole Posaconazole | [1] Posaconazole
Posaconazole
💬
| - | - | [1] 65 65 💬
|
| 650 | PPS | - | - | - | - | [1] 65 65 💬
|
| 651 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 652 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 653 | PREVENAR | - | - | - | - | [1] 65 65 💬
|
| 654 | Prevenar® (7-valent pneumococcal conjugate vaccine) | - | - | - | - | [1] 65 65 💬
|
| 655 | PRIVIGEN | - | - | - | - | [6] 11 11, 14, 51, 63, 65, 222 💬
|
| 656 | Privigen® | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 657 | Procarbazine | [1] Procarbazine Procarbazine | [2] Procarbazine hydrochloride
Procarbazine hydrochloride
,
Procarbazine
💬
| - | - | [1] 65 65 💬
|
| 658 | Progynova 21 mite | - | - | - | - | [1] 65 65 💬
|
| 659 | PROLEUKIN® S | - | - | - | - | [1] 65 65 💬
|
| 660 | Promacta | - | - | - | - | [1] 65 65 💬
|
| 661 | Prometic's Immune Globulin Intravenous 10% | - | - | - | - | [1] 65 65 💬
|
| 662 | PSRS11.EFS.IL2RG.pre* retroviral vector | - | - | - | - | [1] 65 65 💬
|
| 663 | PSRS11.EFS.IL2RG.pre* retroviral vector transduce | - | - | - | - | [1] 65 65 💬
|
| 664 | PSRS11.EFS.IL2RG.pre* retroviral vector transduced cells | - | - | - | - | [1] 65 65 💬
|
| 665 | PTH 1-34 | - | - | - | - | [2] 65 65, 235 💬
|
| 666 | Purified Vero Cell Vaccine) | - | - | - | - | [1] 65 65 💬
|
| 667 | PYRIMETHAMINE | [1] Pyrimethamine Pyrimethamine | [1] Pyrimethamine
Pyrimethamine
💬
| - | - | [4] 2 2, 4, 19, 65 💬
|
| 668 | Quercetin | [1] Quercetin Quercetin | - | - | - | [10] 13 13, 46, 65, 84, 85, 97, 192, 271, 285, 299 💬
|
| 669 | R-hIL-18BP | - | - | - | - | [1] 65 65 💬
|
| 670 | Rabbit | [1] Rabbit Rabbit | - | - | - | [11] 11 11, 13, 49, 51, 60, 62, 65, 96, 283, 285, 326 💬
|
| 671 | Rabbit anti-thymocyte globulin | [1] Rabbit Rabbit | - | - | - | [5] 49 49, 60, 65, 285, 326 💬
|
| 672 | Radiation: Low Dose Total Body Irradiation | - | - | - | - | [2] 65 65, 285 💬
|
| 673 | Radiation: radiation therapy | - | - | - | - | [5] 34 34, 60, 65, 284, 285 💬
|
| 674 | Radiation: Total body 200cGy | - | - | - | - | [1] 65 65 💬
|
| 675 | Radiation: Total Body Irradiation | - | - | - | - | [11] 19 19, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284 💬
|
| 676 | Radiation: total-body irradiation | - | - | - | - | [9] 28 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
|
| 677 | Ranitidine | [1] Ranitidine Ranitidine | [3] Ranitidine
Ranitidine
,
Ranitidine hydrochloride
,
Ranitidine bismuth citrate
💬
| [1] HRH2 HRH2 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 65 💬
|
| 678 | Recombinant human C1 esterase inhibitor | - | - | - | - | [1] 65 65 💬
|
| 679 | Recombinant Human C1 Inhibitor | [1] Conestat alfa Conestat alfa | [1] Conestat alfa
Conestat alfa
💬
| [3] C1R C1R, C1S, KLKB1 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 65 65 💬
|
| 680 | Recombinant human hyaluronidase | [1] Hyaluronidase Hyaluronidase | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| - | - | [1] 65 65 💬
|
| 681 | Recombinant Human Hyaluronidase (rHuPH20) | [1] Hyaluronidase Hyaluronidase | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| - | - | [1] 65 65 💬
|
| 682 | Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV) | [1] Hyaluronidase Hyaluronidase | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| - | - | [1] 65 65 💬
|
| 683 | Recombinant human hyaluronidase + immune globulin intravenous | [1] Hyaluronidase Hyaluronidase | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| - | - | [1] 65 65 💬
|
| 684 | Reduced Intensity Conditioning | - | - | - | - | [2] 19 19, 65 💬
|
| 685 | Reduced Intensity Preparative Regimen | - | - | - | - | [3] 62 62, 65, 284 💬
|
| 686 | Reduced Toxicity Ablative Regimen | - | - | - | - | [3] 62 62, 65, 284 💬
|
| 687 | Retroviral SF71-gp91phox transduced CD34+ cells | - | - | - | - | [1] 65 65 💬
|
| 688 | Retrovirus-mediated gene transfer | - | - | - | - | [1] 65 65 💬
|
| 689 | RhC1IHN | - | - | - | - | [1] 65 65 💬
|
| 690 | RhC1INH | - | - | - | - | [1] 65 65 💬
|
| 691 | RhC1INH or pdC1INH | - | - | - | - | [1] 65 65 💬
|
| 692 | RhuCD40L | - | - | - | - | [1] 65 65 💬
|
| 693 | RI-002 | - | - | - | - | [1] 65 65 💬
|
| 694 | Rifaximin | [1] Rifaximin Rifaximin | [1] Rifaximin
Rifaximin
💬
| - | - | [8] 6 6, 65, 93, 96, 97, 99, 296, 299 💬
|
| 695 | Rimiducid | [1] Rimiducid Rimiducid | [1] Rimiducid
Rimiducid
💬
| [1] CASP9 CASP9 💬
| [34] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬 | [7] 19 19, 49, 60, 65, 284, 285, 326 💬
|
| 696 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 697 | Rituximab (RTX) and Azathioprine (AZA) | [2] Azathioprine Azathioprine, Rituximab | [3] Azathioprine
Azathioprine
,
Rituximab
,
Azathioprine sodium
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 65 65 💬
|
| 698 | Rivogenlecleucel | [1] Rivogenlecleucel Rivogenlecleucel | [1] Rivogenlecleucel
Rivogenlecleucel
💬
| - | - | [6] 19 19, 60, 65, 284, 285, 326 💬
|
| 699 | Romiplostim | [1] Romiplostim Romiplostim | [1] Romiplostim
Romiplostim
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [4] 60 60, 63, 64, 65 💬
|
| 700 | Rosuvastatin | [1] Rosuvastatin Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [16] 6 6, 18, 46, 49, 51, 56, 57, 62, 65, 67, 79, 94, 96, 97, 271, 299 💬
|
| 701 | Rosuvastatin + BCX7353 | [1] Rosuvastatin Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 65 65 💬
|
| 702 | RP-L201 | [1] RP-L201 RP-L201 | [1] Marnetegragene autotemcel
Marnetegragene autotemcel
💬
| [1] ITGB2 ITGB2 💬
| [21] Amoebiasis Amoebiasis, Cell adhesion molecule (CAM) interaction, Complement and coagulation cascades, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Integrin signaling, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Pertussis, Phagocytosis, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Tuberculosis, Viral myocarditis 💬 | [1] 65 65 💬
|
| 703 | Ruconest | - | - | - | - | [1] 65 65 💬
|
| 704 | RUCONEST - 2100 U - POLVERE PER SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 2100 U | - | - | - | - | [1] 65 65 💬
|
| 705 | Ruconest 2100 U powder for solution for injection | - | - | - | - | [1] 65 65 💬
|
| 706 | Ruconest® | - | - | - | - | [1] 65 65 💬
|
| 707 | Ruxolitinib | [1] Ruxolitinib Ruxolitinib | [2] Ruxolitinib
Ruxolitinib
,
Ruxolitinib phosphate
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [7] 13 13, 15, 50, 60, 65, 228, 331 💬
|
| 708 | SC Investigational Needle Sets | - | - | - | - | [2] 14 14, 65 💬
|
| 709 | SC treatment with IGSC, 10% with rHuPH20 followed by IV/IGSC, 10% only (safety) | - | - | - | - | [1] 65 65 💬
|
| 710 | SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety) | - | - | - | - | [1] 65 65 💬
|
| 711 | Sebetralstat | [1] Sebetralstat Sebetralstat | [1] Sebetralstat
Sebetralstat
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 712 | SHP616 | - | - | - | - | [1] 65 65 💬
|
| 713 | SHP623 | - | - | - | - | [1] 65 65 💬
|
| 714 | SHP643 | - | - | - | - | [1] 65 65 💬
|
| 715 | Sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [46] 6 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 716 | Sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [31] 2 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
|
| 717 | Somatic gene-therapy by X-CGD | - | - | - | - | [1] 65 65 💬
|
| 718 | Somatotropin | [1] Somatotropin Somatotropin | [1] Somatropin
Somatropin
💬
| [1] GHR GHR 💬
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [3] 3 3, 65, 236 💬
|
| 719 | Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate | [3] Clonidine Clonidine, Estradiol, Estradiol valerate | [5] Estradiol
Estradiol
,
Clonidine
,
Clonidine hydrochloride
,
Estradiol valerate
,
Estradiol hemihydrate
💬
| [5] ADRA2A ADRA2A, ADRA2B, ADRA2C, ESR1, ESR2 💬
| [13] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 720 | Soquelitinib | [1] Soquelitinib Soquelitinib | [1] Soquelitinib
Soquelitinib
💬
| [1] ITK ITK 💬
| [3] Chemokine signaling pathway Chemokine signaling pathway, Leukocyte transendothelial migration, T cell receptor signaling pathway 💬 | [1] 65 65 💬
|
| 721 | STA-5326 | - | - | - | - | [2] 65 65, 96 💬
|
| 722 | STAR-0215 | - | - | - | - | [1] 65 65 💬
|
| 723 | STAR-0215 (IV) | - | - | - | - | [1] 65 65 💬
|
| 724 | STAR-0215 (SC) | - | - | - | - | [1] 65 65 💬
|
| 725 | Stelara (ustekinumab) | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 65 65 💬
|
| 726 | Stem Cell Infusion | - | - | - | - | [4] 28 28, 60, 65, 284 💬
|
| 727 | Stem Cell Transplant | - | - | - | - | [6] 19 19, 20, 60, 65, 164, 284 💬
|
| 728 | Stem Cell Transplantation | - | - | - | - | [14] 13 13, 19, 20, 46, 48, 51, 60, 62, 65, 90, 125, 164, 234, 326 💬
|
| 729 | Strimvelis | [1] Strimvelis Strimvelis | - | - | - | [1] 65 65 💬
|
| 730 | Subcuvia | - | - | - | - | [3] 14 14, 49, 65 💬
|
| 731 | Subgam | - | - | - | - | [1] 65 65 💬
|
| 732 | Sulfadoxine | [1] Sulfadoxine Sulfadoxine | [1] Sulfadoxine
Sulfadoxine
💬
| - | - | [1] 65 65 💬
|
| 733 | Suspension of autologous CD34+cells transduced with the G1XCGD viral vector | - | - | - | - | [1] 65 65 💬
|
| 734 | T-Cell Depleted & CD34+Select/w/StemCell Enriched Product | - | - | - | - | [1] 65 65 💬
|
| 735 | Tabelecleucel | [1] Tabelecleucel Tabelecleucel | [1] Tabelecleucel
Tabelecleucel
💬
| - | - | [1] 65 65 💬
|
| 736 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
| 737 | Tacrolimus (Tacro) | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 738 | Tadekinig alfa | [1] Tadekinig alfa Tadekinig alfa | - | - | - | [2] 54 54, 65 💬
|
| 739 | TAK-667 | - | - | - | - | [1] 65 65 💬
|
| 740 | TAK-743, SHP643, DX-2930 | - | - | - | - | [1] 65 65 💬
|
| 741 | TAK-771 | - | - | - | - | [2] 14 14, 65 💬
|
| 742 | TAK-881 | - | - | - | - | [2] 14 14, 65 💬
|
| 743 | TAK743 | - | - | - | - | [1] 65 65 💬
|
| 744 | TAKHZYRO | - | - | - | - | [1] 65 65 💬
|
| 745 | Takzhyro (Lanadelumab) | [1] Lanadelumab Lanadelumab | [1] Lanadelumab
Lanadelumab
💬
| [1] KLKB1 KLKB1 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 65 65 💬
|
| 746 | Tamoxifen | [1] Tamoxifen Tamoxifen | [2] Tamoxifen citrate
Tamoxifen citrate
,
Tamoxifen
💬
| [2] ESR1 ESR1, ESR2 💬
| [10] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [6] 2 2, 65, 86, 113, 227, 299 💬
|
| 747 | TCR alfa beta T cell depletion | - | - | - | - | [1] 65 65 💬
|
| 748 | Temozolomide | [1] Temozolomide Temozolomide | [1] Temozolomide
Temozolomide
💬
| - | - | [2] 34 34, 65 💬
|
| 749 | Thalidomide | [1] Thalidomide Thalidomide | [1] Thalidomide
Thalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 2 2, 16, 20, 28, 49, 51, 53, 56, 63, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
|
| 750 | Therapeutic Allogeneic Lymphocytes | [1] Therapeutic allogeneic lymphocytes Therapeutic allogeneic lymphocytes | - | - | - | [3] 60 60, 65, 285 💬
|
| 751 | There is no recommended INN | - | - | - | - | [1] 65 65 💬
|
| 752 | Thiotepa | [1] Thiotepa Thiotepa | [1] Thiotepa
Thiotepa
💬
| - | - | [14] 13 13, 19, 20, 28, 46, 51, 60, 65, 85, 96, 107, 164, 284, 285 💬
|
| 753 | Thiotepa--escalated dose | [1] Thiotepa Thiotepa | [1] Thiotepa
Thiotepa
💬
| - | - | [4] 19 19, 20, 65, 284 💬
|
| 754 | Thiotepa--single daily dose | [1] Thiotepa Thiotepa | [1] Thiotepa
Thiotepa
💬
| - | - | [4] 19 19, 20, 65, 284 💬
|
| 755 | Thymafalsin | - | - | - | - | [1] 65 65 💬
|
| 756 | THYMALFASIN | [1] Thymalfasin Thymalfasin | [1] Thymalfasin
Thymalfasin
💬
| - | - | [1] 65 65 💬
|
| 757 | Thymus Tissue for Transplantation | - | - | - | - | [1] 65 65 💬
|
| 758 | Thymus/Parathyroid Transplantation | - | - | - | - | [2] 65 65, 235 💬
|
| 759 | To be confirmed | - | - | - | - | [3] 46 46, 65, 97 💬
|
| 760 | Tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [26] 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
|
| 761 | Tociluzumab | - | - | - | - | [1] 65 65 💬
|
| 762 | Tofacitinib | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [23] 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
| 763 | Total body Irradiation | - | - | - | - | [6] 19 19, 20, 51, 60, 65, 285 💬
|
| 764 | Total Body Irradiation (TBI) (Plan 1) | - | - | - | - | [3] 60 60, 65, 285 💬
|
| 765 | Total lymphoid irradiation | - | - | - | - | [3] 65 65, 284, 326 💬
|
| 766 | Traditional treatment of CGD and TB | - | - | - | - | [1] 65 65 💬
|
| 767 | Tranexamic acid | [1] Tranexamic acid Tranexamic acid | [1] Tranexamic acid
Tranexamic acid
💬
| [1] PLG PLG 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | [7] 46 46, 65, 70, 215, 227, 274, 299 💬
|
| 768 | Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan | [4] Alemtuzumab Alemtuzumab, Fludarabine, Melphalan, Thiotepa | [6] Melphalan
Melphalan
,
Thiotepa
,
Fludarabine phosphate
,
Alemtuzumab
,
Fludarabine
,
Melphalan hydrochloride
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 164 💬
|
| 769 | TREOSULFAN | [1] Treosulfan Treosulfan | [1] Treosulfan
Treosulfan
💬
| - | - | [6] 13 13, 19, 62, 65, 284, 286 💬
|
| 770 | Triheptanoin | [1] Triheptanoin Triheptanoin | [1] Triheptanoin
Triheptanoin
💬
| - | - | [12] 2 2, 8, 65, 149, 156, 248, 256, 257, 317, 318, 324, 344 💬
|
| 771 | Tuvusertib | [1] Tuvusertib Tuvusertib | [1] Tuvusertib
Tuvusertib
💬
| [1] ATR ATR 💬
| [7] Cell cycle Cell cycle, Cellular senescence, Fanconi anemia pathway, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, p53 signaling pathway 💬 | [1] 65 65 💬
|
| 772 | Umbilical Cord Blood Transplantation | - | - | - | - | [5] 60 60, 65, 284, 285, 326 💬
|
| 773 | Ustekinumab | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [17] 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
|
| 774 | Valproic Acid | [1] Valproic acid Valproic acid | [3] Divalproex sodium
Divalproex sodium
,
Valproic acid
,
Valproate sodium
💬
| [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬
| [16] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [10] 3 3, 5, 26, 34, 65, 89, 90, 145, 222, 331 💬
|
| 775 | Verorab® (PVRV | - | - | - | - | [1] 65 65 💬
|
| 776 | Vigantol | - | - | - | - | [2] 13 13, 65 💬
|
| 777 | Vinblastine | [1] Vinblastine Vinblastine | [2] Vinblastine sulfate
Vinblastine sulfate
,
Vinblastine
💬
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [3] 34 34, 63, 65 💬
|
| 778 | Vinblastine, vincristine, prednisone, daunorubicin | [4] Daunorubicin Daunorubicin, Prednisone, Vinblastine, Vincristine | [8] Prednisone
Prednisone
,
Vinblastine sulfate
,
Daunorubicin hydrochloride
,
Vincristine sulfate
,
Daunorubicin
,
Vinblastine
,
Vincristine
,
Daunorubicin citrate
💬
| [10] NR3C1 NR3C1, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [13] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [1] 65 65 💬
|
| 779 | Vincristine | [1] Vincristine Vincristine | [2] Vincristine sulfate
Vincristine sulfate
,
Vincristine
💬
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [5] 26 26, 34, 63, 65, 331 💬
|
| 780 | Vitamin D3 | - | - | - | - | [12] 6 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 💬
|
| 781 | Vivaglobin | - | - | - | - | [2] 14 14, 65 💬
|
| 782 | VM106 | - | - | - | - | [1] 65 65 💬
|
| 783 | Vorinostat | [1] Vorinostat Vorinostat | [1] Vorinostat
Vorinostat
💬
| [11] HDAC1 HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 💬
| [20] ATP-dependent chromatin remodeling ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬 | [5] 65 65, 75, 96, 97, 156 💬
|
| 784 | VP 20624 | - | - | - | - | [1] 65 65 💬
|
| 785 | Water | [1] Water Water | [1] Water
Water
💬
| - | - | [36] 2 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
|
| 786 | Whole Blood | [1] Whole Blood Whole Blood | [1] Blood, whole
Blood, whole
💬
| - | - | [9] 44 44, 45, 50, 65, 86, 177, 226, 283, 299 💬
|
| 787 | X-Ray Imaging | - | - | - | - | [5] 28 28, 62, 65, 284, 286 💬
|
| 788 | X4P-001 | - | - | - | - | [1] 65 65 💬
|
| 789 | XELJANZ (tofacitinib) | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 65 65 💬
|
| 790 | Xifaxan | - | - | - | - | [2] 65 65, 94 💬
|
| 791 | Zadaxin | - | - | - | - | [2] 65 65, 299 💬
|
| 792 | ZARZIO | - | - | - | - | [3] 38 38, 65, 285 💬
|